Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Pagliuca

Showing results (51-60 of 95) with videos related to

Pageof 10
Sort By:
Leukemia|October 17, 2022
Molecular landscape of immune pressure and escape in aplastic anemiaSimona Pagliuca, Carmelo Gurnari, Colin Hercus, et al.
Current Research in Translational Medicine|September 16, 2025
Optimized GMP-grade Wharton's jelly's mesenchymal stromal cells manufacturing and administration protocol for Graft versus Host disease preventionCécile Pochon, Romain Perouf, Anne-Béatrice Notarantonio, et al.
Blood|March 21, 2024
Paroxysmal nocturnal hemoglobinuria-related thrombosis in the era of novel therapies: a 2043-patient-year analysisCarmelo Gurnari, Hussein Awada, Simona Pagliuca, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 18, 2019
Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disease in Patients Who Received Anti-CD20 after Hematopoietic Stem Cell TransplantationSimona Pagliuca, Côme Bommier, David Michonneau, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2020
Human-Derived α1-Antitrypsin is Still Efficacious in Heavily Pretreated Patients with Steroid-Resistant Gastrointestinal Graft-versus-Host DiseaseLivia Giannoni, Florence Morin, Marie Robin, et al.
Annals of Hematology|February 8, 2020
Thrombocytapheresis and sequential chemotherapy for extreme symptomatic thrombocytosis secondary to myelofibrosis: a case reportPierre-Edouard Debureaux, Anne Brignier, Juliette Soret-Dulphy, et al.
Research Square|April 17, 2023
Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantationSimona Pagliuca, Carmelo Gurnari, Colin Hercus, et al.
American Journal of Hematology|February 23, 2026
PTCy or ATG for Matched Transplantation in MyelofibrosisPatrizia Chiusolo, Andrea Bacigalupo, Rachel Salit, et al.
Nature Communications|May 31, 2023
Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantationSimona Pagliuca, Carmelo Gurnari, Colin Hercus, et al.
Ejhaem|December 18, 2024
Incidence and risk factors of graft failure in allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis in a nationwide pediatric cohort. A study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular TherapyLaura Danhardt, Arnaud Wiedemann, Gerard Michel, et al.
Pageof 10

Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Leukemia|October 17, 2022
Molecular landscape of immune pressure and escape in aplastic anemiaSimona Pagliuca, Carmelo Gurnari, Colin Hercus, et al.
Current Research in Translational Medicine|September 16, 2025
Optimized GMP-grade Wharton's jelly's mesenchymal stromal cells manufacturing and administration protocol for Graft versus Host disease preventionCécile Pochon, Romain Perouf, Anne-Béatrice Notarantonio, et al.
Blood|March 21, 2024
Paroxysmal nocturnal hemoglobinuria-related thrombosis in the era of novel therapies: a 2043-patient-year analysisCarmelo Gurnari, Hussein Awada, Simona Pagliuca, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 18, 2019
Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disease in Patients Who Received Anti-CD20 after Hematopoietic Stem Cell TransplantationSimona Pagliuca, Côme Bommier, David Michonneau, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 27, 2020
Human-Derived α1-Antitrypsin is Still Efficacious in Heavily Pretreated Patients with Steroid-Resistant Gastrointestinal Graft-versus-Host DiseaseLivia Giannoni, Florence Morin, Marie Robin, et al.
Annals of Hematology|February 8, 2020
Thrombocytapheresis and sequential chemotherapy for extreme symptomatic thrombocytosis secondary to myelofibrosis: a case reportPierre-Edouard Debureaux, Anne Brignier, Juliette Soret-Dulphy, et al.
Research Square|April 17, 2023
Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantationSimona Pagliuca, Carmelo Gurnari, Colin Hercus, et al.
American Journal of Hematology|February 23, 2026
PTCy or ATG for Matched Transplantation in MyelofibrosisPatrizia Chiusolo, Andrea Bacigalupo, Rachel Salit, et al.
Nature Communications|May 31, 2023
Leukemia relapse via genetic immune escape after allogeneic hematopoietic cell transplantationSimona Pagliuca, Carmelo Gurnari, Colin Hercus, et al.
Ejhaem|December 18, 2024
Incidence and risk factors of graft failure in allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis in a nationwide pediatric cohort. A study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular TherapyLaura Danhardt, Arnaud Wiedemann, Gerard Michel, et al.
Pageof 10